Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 192
Filter
1.
Sci Rep ; 13(1): 18805, 2023 11 01.
Article in English | MEDLINE | ID: mdl-37914747

ABSTRACT

The TARDBP gene variant is a known major cause of amyotrophic lateral sclerosis (ALS), with limited reports of Korean patients with ALS harboring the variants in TARDBP. This large cohort study introduces four ALS patients who share the p.M337V variant of the TARDBP, allowing for an investigation of clinical characteristics and prognosis by analyzing previously reported cases with the same variant. From November 2014 to August 2022, participants were recruited from two tertiary hospitals in Seoul, Korea. Clinical characteristics of patients diagnosed with ALS carrying the variant in TARDBP were evaluated. Previous articles demonstrating subjects' characteristics were reviewed. Four patients were identified with the pathogenic missense variant (c.1009A>G; p.M337V) in the TARDBP. The mean age of onset was 55 years old, and none of the patients showed severe cognitive impairment. Sixty-three patients carrying the p.M337V variant in TARDBP from this study and previous reports delineated young age of onset (51.6 years), high frequency of bulbar onset patients (61.9%), and low comorbidity of frontotemporal dementia. This study reveals the presence of pathogenic variant of TARDBP in Korea and emphasizes the importance of genetic screening of the TARDBP gene, in diagnosing ALS and evaluating prognosis among familial and simplex ALS patients in Korea.


Subject(s)
Amyotrophic Lateral Sclerosis , Humans , Middle Aged , Amyotrophic Lateral Sclerosis/epidemiology , Amyotrophic Lateral Sclerosis/genetics , Amyotrophic Lateral Sclerosis/pathology , Cohort Studies , Genetic Testing , Mutation , Mutation, Missense , Republic of Korea/epidemiology
2.
PLoS One ; 18(10): e0292460, 2023.
Article in English | MEDLINE | ID: mdl-37831677

ABSTRACT

The available quantitative methods for evaluating bulbar dysfunction in patients with amyotrophic lateral sclerosis (ALS) are limited. We aimed to characterize vowel properties in Korean ALS patients, investigate associations between vowel parameters and clinical features of ALS, and analyze subclinical articulatory changes of vowel parameters in those with perceptually normal voices. Forty-three patients with ALS (27 with dysarthria and 16 without dysarthria) and 20 healthy controls were prospectively collected in the study. Dysarthria was assessed using the ALS Functional Rating Scale-Revised (ALSFRS-R) speech subscores, with any loss of 4 points indicating the presence of dysarthria. The structured speech samples were recorded and analyzed using Praat software. For three corner vowels (/a/, /i/, and /u/), data on the vowel duration, fundamental frequency, frequencies of the first two formants (F1 and F2), harmonics-to-noise ratio, vowel space area (VSA), and vowel articulation index (VAI) were extracted from the speech samples. Corner vowel durations were significantly longer in ALS patients with dysarthria than in healthy controls. The F1 frequency of /a/, F2 frequencies of /i/ and /u/, the VSA, and the VAI showed significant differences between ALS patients with dysarthria and healthy controls. The area under the curve (AUC) was 0.912. The F1 frequency of /a/ and the VSA were the major determinants for differentiating ALS patients who had not yet developed apparent dysarthria from healthy controls (AUC 0.887). In linear regression analyses, as the ALSFRS-R speech subscore decreased, both the VSA and VAI were reduced. In contrast, vowel durations were found to be rather prolonged. The analyses of vowel parameters provided a useful metric correlated with disease severity for detecting subclinical bulbar dysfunction in ALS patients.


Subject(s)
Amyotrophic Lateral Sclerosis , Dysarthria , Humans , Dysarthria/diagnosis , Dysarthria/etiology , Speech Intelligibility , Phonetics , Republic of Korea , Speech Acoustics
3.
Sci Rep ; 13(1): 14360, 2023 09 01.
Article in English | MEDLINE | ID: mdl-37658148

ABSTRACT

Ewing sarcoma (EWS) is a malignant tumor arising in bone or soft tissue that occurs in adolescent and young adult patients as well as adults later in life. Although non-metastatic EWS is typically responsive to treatment when newly diagnosed, relapsed cases have an unmet need for which no standard treatment approach exists. Recent phase III clinical trials for EWS comparing 7 vs 5 chemotherapy drugs have failed to improve survival. To extend the durability of remission for EWS, we investigated 3 non-chemotherapy adjuvant therapy drug candidates to be combined with chemotherapy. The efficacy of these adjuvant drugs was investigated via anchorage-dependent growth assays, anchorage-independent soft-agar colony formation assays and EWS xenograft mouse models. Enoxacin and entinostat were the most effective adjuvant drug in both long-term in vitro and in vivo adjuvant studies. In the context that enoxacin is an FDA-approved antibiotic, and that entinostat is an investigational agent not yet FDA-approved, we propose enoxacin as an adjuvant drug for further preclinical and clinical investigation in EWS patients.


Subject(s)
Neuroectodermal Tumors, Primitive, Peripheral , Sarcoma, Ewing , Humans , Animals , Mice , Sarcoma, Ewing/drug therapy , Enoxacin , Benzamides , Adjuvants, Immunologic , Adjuvants, Pharmaceutic , Disease Models, Animal , Tumor Suppressor Protein p53
4.
J Clin Virol ; 164: 105497, 2023 07.
Article in English | MEDLINE | ID: mdl-37253299

ABSTRACT

BACKGROUND: Rotavirus group A (RVA) is a causative agent of acute gastroenteritis among young children worldwide, despite the global expansion of rotavirus vaccination. In Korea, although the prevalence of RVA has been reduced among young children owing to vaccination, nosocomial infections still occur among neonates. OBJECTIVES: The aim of this study was to investigate the molecular epidemiology of RVA strains associated with several neonatal outbreaks in Seoul from 2017 to 2020. STUDY DESIGN: Clinical and environmental samples were collected and screened for the presence of RVA using ELISA and PCR targeting VP6, respectively. RVA-positive strains were genotyped via RT-PCR and subsequent sequencing of VP4 and VP7 and were phylogenetically compared with RVA strains from other countries. RESULTS: During 2017-2020, a total of 15 RVA outbreaks occurred at neonatal facilities (six in hospital neonatal wards and nine in postpartum care centers) in Seoul, and only two RVA genotypes were detected: G4P[6] and G8P[6]. G8P[6] emerged in Seoul November 2018 and immediately became the predominant genotype among neonates, at least up to 2020. Phylogenetic analysis revealed that the G8P[6] genotype in this study was closely related to G8P[6] strains first identified in Korea in 2017, but differed from G8P[6] strains detected in Africa. CONCLUSIONS: A novel G8P[6] genotype of RVA strains has emerged and caused outbreaks among neonates in Seoul. Continued surveillance for circulating RVA genotypes is imperative to monitor genotype changes and their potential risks to public health.


Subject(s)
Cross Infection , Disease Outbreaks , Molecular Epidemiology , Phylogeny , Rotavirus Infections , Rotavirus , Female , Humans , Infant, Newborn , Feces/virology , Genotype , Rotavirus/genetics , Rotavirus Infections/epidemiology , Rotavirus Infections/virology , Seoul/epidemiology , Cross Infection/epidemiology , Cross Infection/virology , Capsid Proteins/genetics , Environmental Microbiology , Male
5.
Sci Rep ; 13(1): 5528, 2023 04 04.
Article in English | MEDLINE | ID: mdl-37016037

ABSTRACT

Dysregulation of microRNAs (miRNA) in small extracellular vesicles (sEV) such as exosomes have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). Although circulating cell-free miRNA have been extensively investigated in ALS, sEV-derived miRNAs have not been systemically explored yet. Here, we performed small RNA sequencing analysis of serum sEV and identified 5 differentially expressed miRNA in a discovery cohort of 12 patients and 11 age- and sex-matched healthy controls (fold change > 2, p < 0.05). Two of them (up- and down-regulation of miR-23c and miR192-5p, respectively) were confirmed in a separate validation cohort (18 patients and 15 healthy controls) by droplet digital PCR. Bioinformatic analysis revealed that these two miRNAs interact with distinct sets of target genes and involve biological processes relevant to the pathomechanism of ALS. Our results suggest that circulating sEV from ALS patients have distinct miRNA profiles which may be potentially useful as a biomarker of the disease.


Subject(s)
Amyotrophic Lateral Sclerosis , Circulating MicroRNA , Extracellular Vesicles , MicroRNAs , Humans , Amyotrophic Lateral Sclerosis/pathology , Circulating MicroRNA/genetics , MicroRNAs/genetics , Extracellular Vesicles/genetics , Extracellular Vesicles/pathology , Sequence Analysis, RNA
7.
Materials (Basel) ; 15(19)2022 Oct 02.
Article in English | MEDLINE | ID: mdl-36234184

ABSTRACT

We propose an efficient alignment method for liquid crystals (LCs). A brush-coating method handles film deposition and LC alignment treatment simultaneously herein, meaning a reduction in the conventional alignment layer treatment process steps. A lanthanum yttrium strontium oxide (LaYSrO) film prepared by the sol-gel process was used for the alignment layer. Topographical details of the brush-coated LaYSrO films (compared with spin-coated films) were investigated by atomic force microscopy. Spin-coated LaYSrO meant that the film formation alone without orientation treatment represented an isotropic surface. On the other hand, the 270 °C-cured brush-coated LaYSrO showed nano/microstructure with directionality. It indicates that brush-hair sweeping induced shearing stress on the sol state of the LaYSrO, which results in surface anisotropy for LC alignment. The uniform LC alignment state was confirmed by polarized optical microscopy and pretilt analysis. The brush-coated LaYSrO shows fine optical transparency compared to plain and indium-tin-oxide coated glasses, and thermal stability up to 150 °C for LC alignment. Competitive electro-optical performances of the brush-coated LaYSrO were verified in a twisted-nematic LC system compared to those of the conventionally used polyimide layer. Consequently, we expect that the brush-coating process can be an innovative technology for LC alignment.

8.
Biochem Biophys Res Commun ; 621: 101-108, 2022 09 17.
Article in English | MEDLINE | ID: mdl-35820279

ABSTRACT

Over the past 25 years, chemotherapy regimens for osteosarcoma have failed to improve the 65-70% long-term survival rate. Radiation therapy is generally ineffective except for palliative care. We here investigated whether osteosarcoma can be sensitized to radiation therapy targeting specific molecules in osteosarcoma. Large-scale RNA sequencing analysis in osteosarcoma tissues and cell lines revealed that FGFR1 is the most frequently expressed receptor tyrosine kinase in osteosarcoma. Nuclear FGFR1 (nFGFR1) was observed by subcellular localization assays. The functional studies using a FGFR1IIIb antibody or small molecule FGFR1 inhibitors showed that nFGFR1, but not membrane-bound FGFR1, induces G2 cell-cycle checkpoint adaptation, cell survival and polyploidy following irradiation in osteosarcoma cells. Further, the activation of nFGFR1 induces Histone H3 phosphorylation at Ser 10 and c-jun/c-fos expression to contribute cell survival rendering radiation resistance. Furthermore, an in vivo mouse study revealed that radiation resistance can be reversed by the inhibition of nFGFR1. Our findings provide insights into the potential role of nFGFR1 to radiation resistance. Thus, we propose nFGFR1 could be a potential therapeutic target or a biomarker to determine which patients might benefit from radiation therapy.


Subject(s)
Bone Neoplasms , Osteosarcoma , Animals , Bone Neoplasms/drug therapy , Bone Neoplasms/genetics , Bone Neoplasms/radiotherapy , Cell Line, Tumor , Cell Nucleus/metabolism , Cell Survival , Humans , Mice , Osteosarcoma/drug therapy , Osteosarcoma/genetics , Osteosarcoma/radiotherapy , Phosphorylation , Receptor, Fibroblast Growth Factor, Type 1/genetics , Receptor, Fibroblast Growth Factor, Type 1/metabolism
9.
Sci Rep ; 12(1): 7204, 2022 05 03.
Article in English | MEDLINE | ID: mdl-35504925

ABSTRACT

To learn spatiotemporal representations and anomaly predictions from geophysical data, we propose STANet, a spatiotemporal neural network with a trainable attention mechanism, and apply it to El Niño predictions for long-lead forecasts. The STANet makes two critical architectural improvements: it learns spatial features globally by expanding the network's receptive field and encodes long-term sequential features with visual attention using a stateful long-short term memory network. The STANet conducts multitask learning of Nino3.4 index prediction and calendar month classification for predicted indices. In a comparison of the proposed STANet performance with the state-of-the-art model, the accuracy of the 12-month forecast lead correlation coefficient was improved by 5.8% and 13% for Nino3.4 index prediction and corresponding temporal classification, respectively. Furthermore, the spatially attentive regions for the strong El Niño events displayed spatial relationships consistent with the revealed precursor for El Niño occurrence, indicating that the proposed STANet provides good understanding of the spatiotemporal behavior of global sea surface temperature and oceanic heat content for El Niño evolution.


Subject(s)
El Nino-Southern Oscillation , Neural Networks, Computer , Forecasting , Learning
10.
Cell Death Dis ; 13(4): 374, 2022 04 19.
Article in English | MEDLINE | ID: mdl-35440077

ABSTRACT

Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by poor response to standard therapies and therefore unfavorable clinical outcomes. Better understanding of TNBC and new therapeutic strategies are urgently needed. ROR nuclear receptors are multifunctional transcription factors with important roles in circadian pathways and other processes including immunity and tumorigenesis. Nobiletin (NOB) is a natural compound known to display anticancer effects, and our previous studies showed that NOB activates RORs to enhance circadian rhythms and promote physiological fitness in mice. Here, we identified several TNBC cell lines being sensitive to NOB, by itself or in combination. Cell and xenograft experiments showed that NOB significantly inhibited TNBC cell proliferation and motility in vitro and in vivo. ROR loss- and gain-of-function studies showed concordant effects of the NOB-ROR axis on MDA-MB-231 cell growth. Mechanistically, we found that NOB activates ROR binding to the ROR response elements (RRE) of the IκBα promoter, and NOB strongly inhibited p65 nuclear translocation. Consistent with transcriptomic analysis indicating cancer and NF-κB signaling as major pathways altered by NOB, p65-inducible expression abolished NOB effects, illustrating a requisite role of NF-κB suppression mediating the anti-TNBC effect of NOB. Finally, in vivo mouse xenograft studies showed that NOB enhanced the antitumor efficacy in mammary fat pad implanted TNBC, as a single agent or in combination with the chemotherapy agent Docetaxel. Together, our study highlights an anti-TNBC mechanism of ROR-NOB via suppression of NF-κB signaling, suggesting novel preventive and chemotherapeutic strategies against this devastating disease.


Subject(s)
Flavones , Triple Negative Breast Neoplasms , Animals , Cell Line, Tumor , Cell Proliferation , Flavones/pharmacology , Flavones/therapeutic use , Humans , I-kappa B Kinase/metabolism , Mice , NF-kappa B/metabolism , Signal Transduction , Triple Negative Breast Neoplasms/pathology , Xenograft Model Antitumor Assays
12.
Analyst ; 147(9): 1899-1905, 2022 May 03.
Article in English | MEDLINE | ID: mdl-35348149

ABSTRACT

Kinetically trapped hairpin DNA has great potential to dynamically build nanostructures, which can be initiated by sequence-specific nucleic acids. The branched junction, which has a multi-arm structure, is a representative nanostructure of DNA. In this study, we report a nonenzymatic and isothermal signal amplification accompanied by building a 3-arm structure based on a catalyzed hairpin DNA assembly (3-CHA). We improved the signal-to-background ratio of the 3-CHA by suppressing the leakage pathway of 3-CHA, thus eliminating unfavorable reaction sites exposed in the single-stranded region of hairpin DNAs. Background and amplified signals were analyzed with gel electrophoresis and real-time fluorescence monitoring. The limit of detection of the developed 3-CHA was estimated to be 29.3 pM for catalyst DNA at room temperature. Supported by the reduced leakage signal, the implemented 3-CHA showed great potential for detecting low concentrations of target DNA.


Subject(s)
Biosensing Techniques , Nanostructures , Nucleic Acids , Biosensing Techniques/methods , Catalysis , DNA/chemistry , DNA/genetics , Limit of Detection , Nucleic Acids/analysis
13.
Psychopharmacology (Berl) ; 239(3): 935-949, 2022 Mar.
Article in English | MEDLINE | ID: mdl-35179622

ABSTRACT

RATIONALE: ±3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug that shows substantial promise as a psychotherapeutic agent. Still, there is some concern regarding its behavioral toxicity, and its dose-effect relationship is poorly understood. We previously explored the role of dose in the cognitive effects of MDMA in a systematic review of existing literature and found no evidence in animals that MDMA impairs memory at low doses (< 3 mg/kg) but mixed results at high doses (≥ 3 mg/kg). Since this review comprised mostly of single-dose studies and an assortment of methodologies, an empirical dose-ranging study on this topic is warranted. OBJECTIVES: The current study aims to evaluate the conclusion from our systematic review that 3 mg/kg may be the threshold for MDMA-induced amnesia, and to further understand the dose-effect relationship of MDMA on behavioral assays of memory, addiction, and depression. METHODS: We systematically examined the effects of 0.01 to 10 mg/kg MDMA on Pavlovian fear conditioning; behavioral sensitization, conditioned place preference, and conditioned responding; and the Porsolt forced swim test in mice. RESULTS: High doses of MDMA (≥ 3 mg/kg) produced amnesia of fear conditioning memory, some evidence of an addictive potential, and antidepressant effects, while low doses of MDMA (≤ 1 mg/kg) had no effect on these behaviors. CONCLUSIONS: The present dose-ranging study provides further evidence that 3 mg/kg is the threshold for MDMA-induced amnesia. These findings, in addition to our systematic review, demonstrate that careful selection of MDMA dose is critical. High doses (≥ 3 mg/kg) should likely be avoided due to evidence that they can produce amnesia and addiction. Conversely, there is little evidence to suggest that low doses, which are usually administered in clinical studies (approximately 1-2 mg/kg), will lead to these same adverse effects. Ultra-low doses (< 1 mg/kg) are likely even safer and should be investigated for therapeutic effects in future studies.


Subject(s)
N-Methyl-3,4-methylenedioxyamphetamine , Amnesia , Animals , Conditioning, Classical , Depression/chemically induced , Dose-Response Relationship, Drug , Fear , Mice , N-Methyl-3,4-methylenedioxyamphetamine/adverse effects
14.
Oncogene ; 41(11): 1647-1656, 2022 03.
Article in English | MEDLINE | ID: mdl-35094009

ABSTRACT

Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and phenocopies a muscle precursor that fails to undergo terminal differentiation. The alveolar subtype (ARMS) has the poorest prognosis and represents the greatest unmet medical need for RMS. Emerging evidence supports the role of epigenetic dysregulation in RMS. Here we show that SMARCA4/BRG1, an ATP-dependent chromatin remodeling enzyme of the SWI/SNF complex, is prominently expressed in primary tumors from ARMS patients and cell cultures. Our validation studies for a CRISPR screen of 400 epigenetic targets identified SMARCA4 as a unique factor for long-term (but not short-term) tumor cell survival in ARMS. A SMARCA4/SMARCA2 protein degrader (ACBI-1) demonstrated similar long-term tumor cell dependence in vitro and in vivo. These results credential SMARCA4 as a tumor cell dependency factor and a therapeutic target in ARMS.


Subject(s)
Neoplasms , Rhabdomyosarcoma, Alveolar , Rhabdomyosarcoma, Embryonal , Biology , Child , DNA Helicases/genetics , Humans , Nuclear Proteins/genetics , Rhabdomyosarcoma, Alveolar/genetics , Transcription Factors/genetics
15.
Int J Exerc Sci ; 15(1): 1236-1245, 2022.
Article in English | MEDLINE | ID: mdl-36620329

ABSTRACT

Quasi-stiffness (joint stiffness) is often used to characterize leg properties during athletic and other activities and has been reported by a single slope of angle-moment curve. However, the joint angle-moment relationship of some relationship are not effectively represented by a simple linear regression model. Thus, the purpose of this analysis was to investigate the benefits of utilizing a 2nd order polynomial regression (quadratic) model as compared to the linear model when calculating lower extremity joint stiffness incorporating subdivided eccentric phases. Thirty healthy and active college students performed 15 drop jumps from a 30-cm platform. The eccentric phase was identified as the time from initial foot contact (IC) to the lowest vertical position of the center of mass and subdivided into the loading and attenuation phases, separated by the peak vertical ground reaction force. Lower extremity joint stiffnesses (hip, knee, and ankle) for the loading and attenuation phases were calculated using a linear and quadratic model. Multiple 2 by 2 repeated measures ANOVAs were performed. In the post-hoc analyses, the quadratic model had greater goodness-of-fit (r 2 and RMSE) than the linear model (p < .05) for all joints. The quadratic model revealed differences between the loading and attenuation phases for both hip (p = .001) and knee stiffness (p < .001). These results suggest that the quadratic model is more representative of the angle-moment relationship while subdividing the eccentric phase of a drop jump into the loading and attenuation phases.

16.
J Cutan Pathol ; 49(3): 231-245, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34536035

ABSTRACT

BACKGROUND: Appropriate use criteria (AUC) provide patient-centered physician guidance in test selection. An initial set of AUC was reported by the American Society of Dermatopathology (ASDP) in 2018. AUC reflect evidence collected at single timepoints and may be affected by evolving evidence and experience. The objective of this study was to update and expand AUC for selected tests. METHODS: RAND/UCLA (RAND Corporation [Santa Monica, CA]/University of California Los Angeles) methodology used includes the following: (a) literature review; (b) review of previously rated tests and previously employed clinical scenarios; (c) selection of previously rated tests for new ratings; (d) development of new clinical scenarios; (e) selection of additional tests; (f) three rating rounds with feedback and group discussion after rounds 1 and 2. RESULTS: For 220 clinical scenarios comprising lymphoproliferative (light chain clonality), melanocytic (comparative genomic hybridization, fluorescence in situ hybridization, reverse transcription polymerase chain reaction, telomerase reverse transcriptase promoter), vascular disorders (MYC), and inflammatory dermatoses (periodic acid-Schiff, Gömöri methenamine silver), consensus by panel raters was reached in 172 of 220 (78%) scenarios, with 103 of 148 (70%) rated "usually appropriate" or "rarely appropriate" and 45 of 148 (30%), "appropriateness uncertain." LIMITATIONS: The study design only measures appropriateness. Cost, availability, test comparison, and additional clinical considerations are not measured. The possibility that the findings of this study may be influenced by the inherent biases of the dermatopathologists involved in the study cannot be excluded. CONCLUSIONS: AUC are reported for selected diagnostic tests in clinical scenarios that occur in dermatopathology practice. Adhering to AUC may reduce inappropriate test utilization and improve healthcare delivery.


Subject(s)
Dermatology/standards , Pathology, Clinical/standards , Skin Diseases/pathology , Evidence-Based Medicine/standards , Humans , Societies, Medical , United States
19.
J Investig Med ; 70(3): 853-858, 2022 03.
Article in English | MEDLINE | ID: mdl-34930797

ABSTRACT

Although most patients with hepatitis E virus (HEV) infection are asymptomatic or have mild symptoms, its infection is generally underdiagnosed and overlooked. In immunocompromised patients, HEV infection can lead to acute liver failure and death. However, the clinical evidence of HEV infection in hematopoietic stem cell transplant (HSCT) recipients is scarce; thus, we conducted this systematic review and meta-analysis to assess the prevalence of HEV infection in this population. We searched MEDLINE, EMBASE, and the Cochrane Library databases from inception through October 2020 to identify studies that reported the prevalence of HEV infection among HSCT recipients. HEV infections were confirmed by HEV-IgG/IgM or HEV-RNA assay. A total of 1977 patients from nine studies with a follow-up time up to 40 months were included in the final analysis. The pooled prevalence of positive HEV-RNA was 3.0% (95% CI 2.3% to 4.0%). The pooled prevalence of positive HEV-IgG was 10.3% (95% CI 4.5% to 21.8%). The pooled prevalence of de novo HEV infection was 2.9% (95% CI 1.8% to 4.5%). Age and male gender were not associated with HEV-RNA or HEV-IgG positivity in the meta-regression analysis. In conclusion, the prevalence of HEV-IgG in HSCT recipients was about 10%, while the prevalence of HEV-RNA was only 3%. However, further studies that focus on the clinical outcomes in this population are warranted.


Subject(s)
Hematopoietic Stem Cell Transplantation , Hepatitis E virus , Hepatitis E , Hematopoietic Stem Cell Transplantation/adverse effects , Hepatitis Antibodies , Hepatitis E/diagnosis , Hepatitis E/epidemiology , Hepatitis E virus/genetics , Humans , Immunoglobulin G , Immunoglobulin M , Male , Prevalence , RNA, Viral
20.
Am J Case Rep ; 22: e932965, 2021 Dec 12.
Article in English | MEDLINE | ID: mdl-34897265

ABSTRACT

BACKGROUND Autoimmune hemolytic anemia is an acquired disorder resulting in the presence of antibodies against red blood cell (RBC) antigens causing hemolysis. Autoimmune hemolytic anemia is of 2 types, Warm antibody mediated and cold agglutinin disease. Warm autoimmune hemolytic anemia (warm agglutinin disease) usually presents with fatigue and other constitutional symptoms and is diagnosed by the presence of IgG antibodies. The disease can occur as idiopathic or secondary to other autoimmune diseases, infections, or even malignancies. The systemic lupus erythematosus (SLE) is an autoimmune disease prevalent in young females. Autoimmune hemolytic anemia can occur as a part of the SLE spectrum however warm autoimmune hemolytic anemia as the initial manifestation of SLE is extremely rare. CASE REPORT Here, we describe a unique case of a 32-year-old woman who presented with vague clinical presentation found to have warm autoimmune hemolytic anemia and further immunological and inflammatory work-up during and after hospitalization lead to the diagnosis of systemic lupus erythematosus. CONCLUSIONS The systemic lupus erythematosus (SLE) is an autoimmune chronic inflammatory disease with unclear etiology affecting multi organs. Variable presentation in addition to the lack of definite pathognomonic features or tests makes the diagnosis of SLE challenging. On the whole autoimmune hemolytic anemia can not only be part of other disease processes but can be an initial presentation, highlighting the importance of thorough work-up in patients presenting with autoimmune hemolytic anemia to aid in timely diagnosis and management of underlying secondary conditions. It is important for providers to be aware of various disease spectrums that contain autoimmune hemolytic anemia for day-to-day clinical practice.


Subject(s)
Anemia, Hemolytic, Autoimmune , Lupus Erythematosus, Systemic , Adult , Anemia, Hemolytic, Autoimmune/diagnosis , Anemia, Hemolytic, Autoimmune/etiology , Female , Hemolysis , Humans , Immunoglobulin G , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL
...